HYPERION DEFI, INC. Depreciation
HYPERION DEFI, INC. (HYPD) reported Depreciation of $1.13 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-04-15
- HYPERION DEFI, INC. depreciation for fiscal 2024 was $1.13M, a 44.08% increase from fiscal 2023.
- HYPERION DEFI, INC. depreciation for fiscal 2023 was $783.21K.
| Period end | Depreciation 12 month |
|---|---|
| 2024-12-31 | $1.13M 10-K · filed 2025-04-15 |
| 2023-12-31 | $783.21K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |